3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with mazapertine succinate in 1 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (mazapertine succinate) | Trials (mazapertine succinate) | Recent Studies (post-2010) (mazapertine succinate) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 10 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, RM; Brenner, L; Charney, DS; Hoffer, PB; Innis, RB; Krystal, JH; Mochoviak, S; Offord, SJ; Seibyl, JP; Zea-Ponce, Y | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and mazapertine succinate
| Article | Year |
|---|---|
Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Contrast Media; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Piperazines; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Time Factors; Tomography, Emission-Computed, Single-Photon | 1996 |